Revenue from Contracts with Customers (Tables)

12 Months Ended

Dec. 31, 2021

Revenue from Contract with Customer [Abstract]

Sales Reserves Rollforward

The following table reflects activity in the Company's sales reserve accounts:

	Rebates and Chargebacks		Product Returns		Other Sales Deductions		Total
Balance as of December 28, 2018	$	354.3	$	34.0	$	17.1	$	405.4
Provisions	2,347.3		22.2		68.2		2,437.7
Payments or credits	(2,405.8)		(27.8)		(72.1)		(2,505.7)
Balance as of December 27, 2019	295.8		28.4		13.2		337.4
Provisions	2,065.9		28.9		59.5		2,154.3
Provision for Medicaid lawsuit (Note 19) (1)	536.0		—		—		536.0
Payments or credits	(2,701.2)		(30.7)		(60.4)		(2,792.3)
Balance as of December 25, 2020	196.5		26.6		12.3		235.4
Provisions	2,087.1		23.7		55.2		2,166.0
Payments or credits	(2,041.8)		(28.8)		(58.0)		(2,128.6)
Balance as of December 31, 2021	$	241.8	$	21.5	$	9.5	$	272.8

(1)Excludes the $105.1 million that is reflected as a component of operating expenses as it represents a pre-acquisition contingency related to the portion of the liability that arose from sales of Acthar Gel prior to the Company's acquisition of Questcor in August 2014. See Note 19 for further detail on the status of the Medicaid lawsuit.

Disaggregation of Revenue

Product sales transferred to customers at a point in time and over time were as follows:

	Fiscal Year
	2021		2020		2019
Product sales transferred at a point in time	79.4	%	78.9	%	81.8	%
Product sales transferred over time	20.6		21.1		18.2

Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction

Transaction price allocated to the remaining performance obligations

The following table includes estimated revenue from contracts extending greater than one year for certain of the Company's hospital products that are expected to be recognized in the future related to performance obligations that were unsatisfied or partially unsatisfied as of December 31, 2021:

Fiscal 2022	$	112.1
Fiscal 2023	69.7
Thereafter	14.7